We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phenotypic versus Target-based Screening for Drug Discovery

Article   Apr 24, 2018 | by Joanna Owens, PhD, Freelance Writer and Editor, UK

 
Phenotypic versus Target-based Screening for Drug Discovery
 
 
 

RELATED ARTICLES

Microfluidic Diagnostic Tools: Could Doctors Soon Be Obsolete?

Article

The world of microfluidics has generated a host of intricate tools on a microscale, ranging from cheap paper-based lateral flow tests to organ-on-a-chip models designed to facilitate personalized diagnostic tests.
This article explores the extent to which microfluidic tools are filling a gap in clinical and point-of-care diagnostics, and touches on how microfluidics could improve the drug discovery process.

READ MORE

The Genetics of Coffee Consumption

Article

Marilyn Cornelis, of the Feinberg School of Medicine at Northwestern University, has spent years researching how coffee affects our body. In this interview, she explains how coffee affects our brain, interacts with cannabis, and why listening to your body might be the best way to decide how much coffee to drink.

READ MORE

Chemical Snapshots and Molecular Maps with Mass Spec Imaging

Article

Mass spectrometry imaging (MSI) is a powerful tool increasingly being used in many fields including cancer research, biomarker discovery and drug development. This article explains why MSI is the technique of choice in many labs, discusses its use in research, and covers how some inherent challenges are being addressed.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE